This meta-analysis demonstrates that ESR1 mutations are found at high frequency in liquid biopsies of ER+ recurrent/metastasized BC and could be tracked relatively simply and inexpensively using both ddPCR and NGS technologies. This evidence concerns the gene ESR1 and breast cancer.